Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Post by Frictionon Sep 05, 2000 8:14pm

342 Views

Post# 2441015

confidense

I grow more and more confident about this one day by day. I have held it for a while, and have always felt it would e gem one day. I feel the day coming. Not only do I have a lot of money on the line with this one, but I have convinced some family memebers and a few guys at work to throw some money into it too. Mine name will be mud if my hunch is not right. I dont want the golf season to be over, but I can't wait until October. (It snows here early.) way long

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects